Associations of low density lipoprotein particle composition with atherogenicity

被引:55
作者
Lada, AT [1 ]
Rudel, LL [1 ]
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Arteriosclerosis Res Program, Winston Salem, NC 27157 USA
关键词
cholesterol; cholesteryl ester fatty acids; coronary heart disease; low density lipoproteins; triacylglycerol;
D O I
10.1097/00041433-200402000-00005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose of review A growing body of data suggests that in addition to LDL-cholesterol concentrations, compositional properties of LDL, including size and fatty acid composition, are important in determining the relative degree of atherogenicity. This review examines current research in this field to evaluate which properties of LDL may most directly influence the risk of coronary heart disease. Recent findings The presence of small dense LDL has been correlated with an increased risk of coronary heart disease, but this has not been shown to be fully independent of related factors such as elevated plasma triacylglycerol concentrations. An increased susceptibility of small dense LDL to in-vitro oxidation has also been demonstrated, but its importance to coronary heart disease risk has not been established. Other studies have found that the presence of enlarged LDL, modified (oleate enriched) fatty acyl composition of LDL, and higher numbers of LDL particles in plasma also are endpoints associated with an increased risk of coronary heart disease. Summary LDL size may indicate a metabolic condition associated with increased CHID risk as opposed to the direct promotion of atherosclerosis by specific particle types of LDL. In most claims of detrimental effects of small dense LDL, neither LDL particle concentrations nor the fatty acid composition of the particles were established, both factors being important in contributing to the atherogenic potential of LDL. The predisposition to premature coronary heart disease cannot currently be objectively assigned to any one type of LDL particle.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 80 条
[1]  
[Anonymous], AM HEART J
[2]   Metabolic origins and clinical significance of LDL heterogeneity [J].
Berneis, KK ;
Krauss, RM .
JOURNAL OF LIPID RESEARCH, 2002, 43 (09) :1363-1379
[3]  
Bhatnagar D, 2003, INT J CLIN PRACT, V57, P305
[4]   Lipoprotein abnormalities related to women's health [J].
Bittner, V .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (8A) :77I-84I
[5]   Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system [J].
Bjornheden, T ;
Babyi, A ;
Bondjers, G ;
Wiklund, O .
ATHEROSCLEROSIS, 1996, 123 (1-2) :43-56
[6]   Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women [J].
Blake, GJ ;
Otvos, JD ;
Rifai, N ;
Ridker, PM .
CIRCULATION, 2002, 106 (15) :1930-1937
[7]   Urbanization elicits a more atherogenic lipoprotein profile in carriers of the apolipoprotein A-IV-2 allele than in A-IV-1 homozygotes [J].
Campos, H ;
LopezMiranda, J ;
Rodriguez, C ;
Albajar, M ;
Schaefer, EJ ;
Ordovas, JM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (06) :1074-1081
[8]   Low-density lipoprotein size, pravastatin treatment, and coronary events [J].
Campos, H ;
Moye, LA ;
Glasser, SP ;
Stampfer, MJ ;
Sacks, FM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (12) :1468-1474
[9]   PREDOMINANCE OF LARGE LDL AND REDUCED HDL(2) CHOLESTEROL IN NORMOLIPIDEMIC MEN WITH CORONARY-ARTERY DISEASE [J].
CAMPOS, H ;
ROEDERER, GO ;
LUSSIERCACAN, S ;
DAVIGNON, J ;
KRAUSS, RM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (08) :1043-1048
[10]   Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity [J].
Chan, DC ;
Watts, GF ;
Mori, TA ;
Barrett, PHR ;
Redgrave, TG ;
Beilin, LJ .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2003, 77 (02) :300-307